Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer-Reference-Cited by-同舟云学术

Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer

Published:2016-09-19 Issue:12 Volume:36 Page:1721-1732
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Castagnoli L,Ghedini G C,Koschorke A,Triulzi T,Dugo M,Gasparini P,Casalini P,Palladini A,Iezzi M,Lamolinara A,Lollini P L,Nanni P,Chiodoni C,Tagliabue E,Pupa S M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2016338.pdf

Reference45 articles.

1. Prat A, Carey LA, Adamo B, Vidal M, Tabernero J, Cortes J et al. Molecular features and survival outcomes of the intrinsic subtypes within HER2-positive breast cancer. J Natl Cancer Inst 2014; 106: dju152.

2. Shiu KK, Wetterskog D, Mackay A, Natrajan R, Lambros M, Sims D et al. Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies. Oncogene 2014; 33: 619–631.

3. Zagozdzon R, Gallagher WM, Crown J . Truncated HER2: implications for HER2-targeted therapeutics. Drug Discov Today 2011; 16: 810–816.

4. Weigelt B, Reis-Filho JS . Activating mutations in HER2: neu opportunities and neu challenges. Cancer Discov 2013; 3: 145–147.

5. Jackson C, Browell D, Gautrey H, Tyson-Capper A . Clinical significance of HER-2 splice variants in breast cancer progression and drug resistance. Int J Cell Biol 2013; 2013: 973584.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resistance to Anti-HER2 Therapies in Gastrointestinal Malignancies;Cancers;2024-08-15

2. Expression of c-erb-B2 oncoprotein as a neoantigen strategy to repurpose anti-neu antibody therapy in a model of melanoma;2024-04-03

3. Loss of the extracellular matrix glycoprotein EMILIN1 accelerates Δ16HER2-driven breast cancer initiation in mice;npj Breast Cancer;2024-01-06

4. Growth Factor Receptor Implications in Breast Cancer: Prospects for Their Molecular Transactivation in the Future and Obstacles for Target Therapy;Interdisciplinary Cancer Research;2024

5. Immunotherapy guided precision medicine in solid tumors;Advances in Protein Chemistry and Structural Biology;2024